4
Changes in Ownership
Aligos Therapeutics, Inc. Filed Acc 0001610717-23-000320
Director bought 7,933,601 shares at $0.76 ($6,004,149)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nuechterlein Carole Director | 2023-10-25 | Purchase | +7,933,601 | $0.76 | $6,004,149 | 11,025,941 | I |
| Derivatives | |||||||
| Nuechterlein Carole Director | 2023-10-25 | Purchase · Warrant (Right to Buy) | +3,966,800 | $0.13 | $495,850 | 3,966,800 | I |
| Open-market purchases · 7,933,601 sh · avg $0.76 · $6,004,149 | |||||||
Loading xslF345X05/form4.xml…